Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
NCT01159613 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2010-07-09
Summary
The working hypothesis is that the low HDL serum level predict favorable response to anti viral treatment in chronic HCV (genotype 1) viral infection. This might be used to improve the rate of sustained virologic response.
Conditions
- Chronic Hepatitis C Viral Infection
Interventions
- OTHER
-
Responders
Responders
- OTHER
-
Non Responders
Non Responders
Sponsors & Collaborators
-
Hillel Yafe MC Hadera
collaborator UNKNOWN -
Ziv Hospital
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2008-10-31
- Completion
- 2009-01-31
Countries
- Israel
Study Locations
More Related Trials
-
Antiviral Pharmacology and Adherence in Drug Users
NCT02573376 ·Status: COMPLETED ·Phase: NA
-
Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection
NCT02597166 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
NCT03413696 ·Status: COMPLETED
-
A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers
NCT04366973 ·Status: COMPLETED
-
Vitamin D Treatment in Patients With Chronic Hepatitis C
NCT00804752 ·Status: UNKNOWN ·Phase: NA
-
Relinking Diagnosed But Untreated HCV Patients Back Into Care.
NCT05975216 ·Status: COMPLETED
-
The Incidence of Occult Hepatitis C Virus Infection in Hemodialysed Patients With Liver Enzymes Disturbances
NCT01054664 ·Status: UNKNOWN
-
HCV-Smoking Cessation Study
NCT05466981 ·Status: COMPLETED ·Phase: NA
-
Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral Medication
NCT00188201 ·Status: UNKNOWN
-
Expression of Inflammasomes in HCV Patients
NCT04244383 ·Status: UNKNOWN ·Phase: PHASE4
-
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
NCT02294136 ·Status: COMPLETED ·Phase: NA
-
Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
NCT02650024 ·Status: COMPLETED
-
Natural History of Hepatitis C in Patients With Normal Liver Tests
NCT00187473 ·Status: COMPLETED
-
Hepatitis C Virus (HCV) Treatment Completion or Withdrawal
NCT00674492 ·Status: COMPLETED
-
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
NCT02641158 ·Status: COMPLETED ·Phase: NA
-
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
NCT01448915 ·Status: COMPLETED
-
Re-link HCV in Substance-Use Telemedicine Program
NCT06349902 ·Status: RECRUITING
-
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
NCT00788918 ·Status: COMPLETED ·Phase: NA
-
Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients
NCT00871845 ·Status: TERMINATED ·Phase: NA
-
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
NCT01474811 ·Status: COMPLETED
-
A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
NCT00218192 ·Status: COMPLETED ·Phase: PHASE3
-
Hepatitis C Self-Management
NCT00328042 ·Status: COMPLETED ·Phase: NA
-
Pharmacist-led Hepatitis C Management
NCT04322981 ·Status: UNKNOWN ·Phase: PHASE4
-
Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors
NCT01813266 ·Status: WITHDRAWN
-
Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs
NCT03170076 ·Status: UNKNOWN